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flexibility on the other. The idea is that higher prefrontal DA levels 
promote cognitive stability by supporting working memory and 
increasing the resistance against distractors, whereas higher striatal 
DA levels promote cognitive flexibility by allowing the updating of 
novel relevant representations or the processing of goal-unrelated 
but nevertheless important information. Even though both stabil-
ity and flexibility are important for proper cognitive functioning, 
shifting to one or the other extreme can be very counterproductive: 
too much stability would result in rigidity and too much flexibility 
in distractibility, either of which poses a major control dilemma 
(Goschke, 2000). Keeping stability and flexibility in proper balance, 
according to Cools and D’Esposito (2009), relies on continuous 
reciprocal adjustments of the prefrontal and striatal DA levels that 
are assumed to underlie these control functions. In terms of this 
assumed reciprocal relationship, 9-repeat carriers of the DAT1 gene 
with their higher striatal DA levels would be expected to be more 
biased towards the flexibility pole of the stability–flexibility dimen-
sion than 10-repeat carriers would be.
In the present study, we tested this hypothesis by applying it to 
the inhibition of return (IOR) effect (Posner and Cohen, 1984), 
a particularly reliable phenomenon in human attention that has 
been  hypothesized  to  promote  flexibility.  It  is  observed  when 
people attend sequential displays or scan complex visual scenes 
(Klein, 1988), or in other circumstances where they move their 
attentional focus from one object to another until an interesting or 
searched-for object has been found. As Posner and Cohen (1984) 
have shown, cuing the location of a visual target by means of a 
randomly varying, peripheral stimulus (e.g., a flash at the loca-
tion where the target will occur) can improve performance at very 
short stimulus-onset asynchronies (SOAs) but impairs perform-
ance at longer SOAs. Once a given location has been inspected and 
IntroductIon
In the regulation of human cognition dopamine (DA) plays a key 
role, mainly through regulating the interplay between the prefrontal 
cortex (PFC) and the striatum. Some progress has been made in 
identifying genetic markers for the individual components of this 
interplay. For instance, the enzyme catechol-O-methyltransferase 
(COMT) is responsible for the degradation of DA in PFC (Karoum 
et al., 1994), while the DA transporter (DAT) is responsible for DA 
reuptake in the striatum (Sesack et al., 1998). Genetic variations 
in the dopamine transporter gene (DAT1) and the COMT gene 
(Val158Met polymorphism) have received increasing attention as 
possible modulators of cognitive control functions (Cools, 2008; 
Cools and D’Esposito, 2009).
The DAT1 gene is located on chromosome 5p15.3 (Giros et al., 
1992; Vandenbergh et al., 1992) and contains a 40 base pair variable 
number of tandem repeats in the 30-untranslated region (3′UTR-
VNTR). Alleles from 3 to 13 repeats have been described, but the 
alleles with 9 and 10 repeats are the most frequently reported (Kang 
et al., 1999; Mitchell et al., 2000). The 9-repeat allele of the DAT1 
gene has been associated with higher DA levels in the striatum 
relative to the 10-repeat allele. Recently, Bertolino et al. (2006) have 
observed similar effects on neuronal activity of the 10-repeat allele 
of the DAT1 gene and the Met allele of the COMT gene (associated 
with high prefrontal DA levels): the brain-activation patterns of 
subjects with putatively low striatal DA levels resembled that seen 
in subjects with putatively high prefrontal DA levels.
Cools (2008) and Cools and D’Esposito (2009), based on such 
reciprocal effects of prefrontal and striatal dopamine levels (and 
of corresponding effects of genes controlling such levels), have 
recently suggested that dopamine plays a key role in controlling the 
balance between cognitive stability on the one hand and cognitive 
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Cohen, 1984). DAT1 might affect the time course resulting from this 
interplay between facilitation and inhibition, be it by shortening 
the duration of the facilitatory component (e.g., by accelerating the 
attentional disengagement from the cue; cf., Lupianez et al., 2004) 
and/or by leading to an earlier onset of the inhibitory component. 
In any case, the relative strength of the inhibitory process would 
be greater in 9-repeat carriers. If so, the transition from facilita-
tion to inhibition would be faster in these individuals, so that the 
maximum IOR would be reached after a shorter SOA in 9-repeat 
than in 10-repeat carriers. Obviously, these two possibilities do not 
necessarily exclude each other, so that 9-repeat carriers may show 
both a faster build-up of net IOR and a higher maximum.
In a previous study of ours on the relationship between COMT 
and task switching (Colzato et al., 2009), we observed a pattern 
that fits better with the second option: Val/Val and Met/ − carriers 
showed comparable task-switching costs and longer preparation 
intervals, whereas Val/Val carriers (which are assumed to have lower 
prefrontal and higher striatal DA levels) were faster to switch at 
short intervals. Apparently, genetic differences affected efficiency 
and speed rather than maximum performance in this particular 
case. However, with respect to DAT1 effects, the available evidence 
does not allow preferring one possibility over the other. We there-
fore studied the time course of IOR over a wider interval, ranging 
from 150 to 1200 ms, to see whether 9-repeat carriers would pro-
duce a higher maximum IOR or just reach that maximum earlier 
than 10/10 homozygous carriers.
MaterIals and Methods
PartIcIPants
Hundred-forty-four  young  Caucasian  healthy  adults 
(67 male/73 female), with a mean age of 21.9 years (SD = 2.6, range 
18–30) and 115.5 IQ (SD = 3.1, range 100–130); served as partici-
pants for partial fulfillment of course credit or a financial reward. 
The sample was drawn from adults in the Leiden and Rotterdam 
metropolitan area (The Netherlands), who volunteered to par-
ticipate in studies of behavioral genetics. Exclusion criteria were 
any major medical illness that could affect brain function, current 
and/or past substance abuse, neurological conditions, history of 
head injury, and personal history of psychiatric medical treatment. 
Participants were selected via a phone interview using the mini 
international neuropsychiatric interview (MINI; Lecrubier et al., 
1997). The MINI is a well established brief diagnostic tool in clini-
cal and stress research (Sheehan et al., 1998; Elzinga et al., 2007; 
Elzinga et al., 2008) that screens for several psychiatric disorders 
including schizophrenia, depression, mania, ADHD, and obses-
sive-compulsive disorder. Written informed consent was obtained 
from all participants after the nature of the study was explained to 
them; the protocol was approved by the ethical committee of the 
Department of Psychology at Leiden University.
aPParatus, stIMulI, and task
The experiment was controlled by a PC attached to a 17-inch monitor 
with a refresh rate of 100 Hz. The task was modeled after Castel et al. 
(2003). The experiment took place in a dimly illuminated, sound 
attenuated room. Participants were seated 45 cm in front of a compu-
ter monitor. They were asked to fixate on a central cross (0.1° 3 0.1°) 
and to make no eye movements during the experimental trials.
  attention has moved to another location, the time needed to return 
to that previous location is increased – presumably to enhance the 
efficiency of attentional scanning by biasing it away from irrelevant, 
old information and to prepare the system for the intake of novel 
information (Klein, 1988).
Considering that the DAT1 gene is associated with DA availabil-
ity in the striatum (provided by the substantia nigra), there are a 
number of reasons suggesting that DAT1 might impact IOR. IOR is 
enhanced after the intake of d-amphetamine (Fillmore et al., 2005), 
and is reduced in Parkinson’s patients and Huntington’s patients, 
who suffer from a loss of nigrostriatal dopaminergic cells and of a 
bilateral neural degeneration of the striatum, respectively (Filoteo 
et al., 1997; Yamaguchi and Kobayashi, 1998; Couette et al., 2008). 
These studies fit with the proposed crucial role of dopamine as 
neurobiological mechanism underlying IOR (Poliakoff et al., 2003). 
Moreover, Colzato and Hommel (2009) found that in contrast to 
cocaine-free controls, recreational cocaine users do not show a 
reliable IOR. At long term, chronic use of cocaine is associated 
with reduced functioning of dopaminergic D2 (DAD2) receptors 
(Volkow et al., 1999), which are involved in regulating the func-
tional expression of DAT1 (Meiergerd et al., 1993; Dickinson et al., 
1999; Mortensen and Amara, 2003).
The goal of the present study was thus to examine whether 
individual  differences  related  to  the  DAT1  polymorphism  can 
predict the magnitude and/or temporal characteristics of the IOR 
effect. Given that previous studies showed reduced IOR in popu-
lations affected by reduced striatal DA activity, such as cocaine 
users, Parkinson’s and Huntington’s patients (Filoteo et al., 1997; 
Yamaguchi and Kobayashi, 1998; Couette et al., 2008; Colzato and 
Hommel, 2009), we expected 10/10 homozygous carriers (presum-
ably combining relatively low striatal and relatively high prefrontal 
DA levels) to show a smaller IOR than 9-repeat carriers (presum-
ably combining relatively high striatal and relatively low prefrontal 
DA levels). In the sense of Cools and D’Esposito (2009), we thus 
expected 9-repeat carriers to show more evidence of attentional 
flexibility, as expressed by more IOR.
Although the prediction of the main effect of DAT1 on IOR is 
straightforward, the impact of the gene on the time course of IOR is 
more difficult to predict. There are at least two, not mutually exclu-
sive possibilities to consider. On the one hand, the higher striatal DA 
levels in 9-repeat carriers may allow for more or stronger inhibition, 
which would imply that the maximum magnitude IOR reached by 
these individuals would be higher than in 10/10 homozygous car-
riers. Alternatively, the combination of lower prefrontal and higher 
striatal DA levels in 9-repeat carriers may speed up the processes 
responsible for the behavioral expression of IOR without neces-
sarily leading to a stronger effect. IOR is commonly assumed to 
reflect the net result of two concurrent processes: a facilitatory 
effect that quickly decays (presumably a spillover of cue-induced 
neural activity; cf., Fecteau and Munoz, 2005) and the build-up 
of a longer-lasting inhibitory effect. The size of IOR at any given 
moment is thus the result of the current relative strength of the 
facilitatory and the inhibitory process – with the former being more 
dominant at short SOAs (so that, on average, performance is bet-
ter if cue and target appear at the same location) and the latter 
becoming more dominant (and performance being better if cue and 
target appear at different locations) as SOA increases (Posner and Frontiers in Human Neuroscience  www.frontiersin.org  July 2010  | Volume 4  | Article 53  |  3
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The sequence of events is shown in Figure 1. All stimuli were 
presented in white (77.0 cd/m2) on a black background (0.5 cd/
m2). The initial display was presented for 1000 ms and consisted 
of two placeholder boxes located on the horizontal meridian to 
the left and right of the fixation point. The boxes were centered 
58 from the fixation point and were 18 square. One of the boxes 
was then cued by outlining the perimeter for 50 ms. One of five 
randomly determined SOAs then followed the onset of the cue 
(50, 250, 750, 1000, 1500 ms). After the variable SOA, a target 
circle (0.78 cm) appeared in one of the two boxes (on 80% of 
the trials; the remaining 20% served as catch trials in which no 
target was presented). Participants were asked to respond to the 
target as quickly and as accurately as possible by pressing the 
space bar of the computer keyboard (regardless of the location 
of the target) and to remain fixated throughout each trial. The 
next trial began 500 ms later. The experiment consisted of 300 
trials with cues and targets being equally likely to occur at the 
left and right locations.
dna laboratory analysIs
Genomic  DNA  was  extracted  from  saliva  samples  using  the 
OrageneTM DNA self-collection kit following the manufacturer’s 
instructions (DNA Genotek, Inc., 2006).
The DAT1 polymorphism was amplified on an MJ DNA engine 
thermal cycler (MJ Research) with an initial denaturation at 94°C 
for 4 min, followed by 32 cycles of 45 s at 94°C, 45 s at 68°C, and 60 s 
at 72°C, and a final elongation of 5 min at 72°C. The 25-ml reaction 
mixture consisted of 50 mM Tris (pH 9.0), 20 mM NH4SO4, 3 mM 
MgCl2, 200 mM dNTPs, 0.5 mM primers, and 1 U Taq polymerase 
(Invitrogen). Products were electrophoresed on 2% agarose gel and 
visualized with ethidium bromide. The oligo primer sequences used 
to amplify the VNTR are DAT1-F: 5′-TgT ggT gTA ggg AAC ggC 
CTg Ag-3′ DAT1-R: 5′-CTT CCT ggA ggT CAC ggC TCA Agg, as 
originally described in Waldman et al. (1998). Each individual was 
genotyped twice.
DNA samples were unobtainable from four participants and 
these adults were excluded from any further analysis.
Procedure and desIgn
All participants were tested individually. Individual IQs were 
determined by means of a 30-min reasoning-based intelligence 
test (SPM). The SPM assesses the individual’s ability to create 
perceptual relations and to reason by analogy independent of 
language and formal schooling; it is a standard, widely used test to 
measure Spearman’s g factor and of fluid intelligence in particular 
(Raven et al., 1988). Participants provided completed the SPM and 
subsequently performed on the behavioral task measuring IOR. 
The behavioral task took about 20-min. Participants were allowed 
to take a short break (maximal 5 min) between task blocks.
statIstIcal analysIs
Independent samples t-tests were performed for analysis of age, 
sex, IQ differences between 10/10 homozygous and 9-repeat car-
riers. The effect of DAT1 genotype on IOR was assessed by means 
of 2 × 2 × 5-ANOVAs with DAT1 (10/10 homozygous vs. 9-repeat 
carriers) as between-subject factor, and Trial Type (i.e., cued vs. 
uncued) and SOA (5 SOAs) as within-subject factor. We adopted 
a significance level of p < 0.05 for all statistical tests.
results
The genotype distribution of the DAT1 polymorphism in our 
population was 82 10/10 homozygous subjects (58.35%) and 58 
9-repeat carriers subjects (41.65%). The allelic distribution of the 
gene was in Hardy–Weinberg equilibrium (p < 0.1). No significant 
differences among genotype frequencies were found with respect to 
age, t(138) = 0.703, p = 0.48, sex, t(138) = 1.29 p = 0.20, or estimated 
IQ, t(138) = 0.35, p = 0.72.
Table 1 provides an overview of the outcomes for RTs and 
proportion of errors (PEs). RTs revealed a significant main effect 
of Trial Type, F(1,138) = 341.41 p < 0.00001, MSE = 597.36, 
η2 p = 0.71; and of SOA, F(4,552) = 76.49 p < 0.0001, MSE = 460.56, 
η2 p = 0.36. These two main effects were involved in two-way inter-
action, F(1,138) = 8.43 p < 0.05, MSE = 597.36, η2 p = 0.06, and in 
a three-way interaction involving DAT, F(4,552) = 3.01 p < 0.05, 
MSE = 290.38, η2 p = 0.03.
Both 10/10 homozygous and 9-repeat carriers showed a sig-
nificant main effect of Trial Type, F(1,57) = 190.26, p < 0.0001, 
MSE = 612.659, η2p = 0.77; and F(1,81) = 149.04, p < 0.0001, 
MSE = 586.599, η2 p = 0.65; respectively. However, t-tests com-
paring the magnitudes of the IOR effect revealed a significant 
difference between 10/10 homozygous and 9-repeat carriers in 
the shortest two SOAs (50 and 250 ms), t(138) = 2.31, p = 0.022; 
and t(138) = 3.75, p = 0.0001, respectively, but not in the longer 
SOAs (750, 1000, 1500 ms), t(138) = 0.79, p = 0.432; t(138) = 1.40, 
p = 0.16; and t(138) = 0.08, p = 0.933. As obvious from Figure 2, 
9-repeat and 10/10 homozygous carriers eventually reached the 
same maximum IOR, but the former reached it faster and earlier 
than the latter.
Figure 1 | illustration of the sequence of events for a non-catch trial 
(SOA, stimulus-onset asynchrony).Frontiers in Human Neuroscience  www.frontiersin.org  July 2010  | Volume 4  | Article 53  |  4
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or estimated IQ, we can rule out confounds with regard to these 
variables. In our case, the matching of the age range was of par-
ticular importance, as both inhibitory output control and IOR are 
known to be unrelated to general intelligence but sensitive to age 
(Logan, 1994; Castel et al., 2003; Langley et al., 2007).
Generally speaking, our observations are consistent with the 
assumption of a crucial role of dopaminergic pathways in IOR, 
as suggested by Poliakoff et al. (2003). They are also in line with 
patients and drug studies showing a reduced IOR in the case of 
striatal dopaminergic hypoactivity (Filoteo et al., 1997; Yamaguchi 
and Kobayashi, 1998; Couette et al., 2008; Colzato et al., 2009) 
and increased IOR in the case of enhanced striatal dopaminer-
gic activity (Fillmore et al., 2005). More specifically, our findings 
provide support for the consideration of Cools (2008) and Cools 
and D’Esposito (2009) that higher striatal DA levels may promote 
cognitive flexibility. If we take the mechanism underlying IOR to 
bias the cognitive system towards the intake of novel information 
(Klein, 1988), our findings suggest that 9-repeat carriers of the 
DAT1 gene are biased towards flexibility rather than stability, at 
least as compared to 10-repeat carriers.
We can only speculate exactly how striatal DA levels manage to 
produce such a bias. There is strong, uncontroversial evidence for 
a crucial role of the superior colliculus in the emergence of IOR. 
One example is the study of Dorris et al. (2002), who used single-
cell recordings to investigate the neural responses in the superior 
colliculus of the monkey. Neural responses to the target stimulus 
were reduced if it was preceded by a cue in the same location, and 
the amount of reduction was correlated with the behavioral IOR 
effect. However, the neurons coding for the cue were no less but, 
if anything, more active after the cue presentation, suggesting that 
the reduced response to the target was not simply a result of the 
integration of cue- and target-related activation. In other words, 
IOR is reflected in the neural response of the superior colliculus 
but it is not created there.
A series of pharmacological single-cell studies by Hikosaka 
and Wurtz (1985a,b) suggests one possible origin. Hikosaka and 
Wurtz (1985a) provided evidence that regional activation of the 
superior colliculus is controlled by collicular GABA neurons, that 
hold the system in (inhibitory) check and allow for saccades and 
In the error analysis, SOA produced a main effect, F(1,552) = 13.87, 
p < 0.0001, MSE = 38.167, η2 p = 0.09, due to fewer errors when 
the task was repeated than alternated. DAT1 was not involved in 
any significant effect.
dIscussIon
Our  findings  provide  evidence  that  DAT1,  a  gene  coding  the 
dopamine transporter (DAT) responsible of DA reuptake in the 
striatum (Sesack et al., 1998), modulates inhibitory input control, 
as indexed by IOR. Interestingly, 9-repeat carriers (with presum-
ably higher striatal DA levels) showed an IOR that was comparable 
to that obtained in 10/10 homozygous individuals with respect 
to its maximum size, but they reached it at shorter SOAs already. 
Apparently, then, DAT1 affects mainly the temporal dynamics of 
the interplay between facilitation and inhibition in the transition 
from cue-induced priming to the peak of IOR but not the maxi-
mum strength of inhibitory input control or the decay back towards 
baseline. In the absence of any hint to contributions from age, sex, 
Figure 2 | Mean cueing effects (uncued reaction time, or rT, minus cued 
rT) at each stimulus-onset asynchrony (SOA) as a function of DAT 
polymorphism (10/10 homozygous vs. 9-repeat carriers). Positive numbers 
indicate facilitation; negative numbers indicate inhibition of return. Error bars 
indicate standard errors of the mean.
Table 1 | Mean response latencies (in ms), error rates (in percent), and ior effect (uncued – cued) for 9-repeat carriers and 10/10 Homozygous 
individuals. 
Variables (SD)  Nine-repeat carriers  10/10 Homozygous
SOA  50  250  750  1000  1500  50  250  750  1000  1500
CueD
RT (ms)  375 (5)  366 (6)  370 (6)  361 (6)  357 (6)  375 (4)  361 (5)  375 (5)  366 (5)  364 (5)
Error rates (%)  0.4 (0.2)  1.5 (0.4)  2.6 (0.5)  3.3 (0.5)  3.2 (0.5)  0.2 (0.2)  1.2 (0.3)  2.2 (0.4)  2.4 (0.4)  2.0 (0.4)
uNCueD
RT (ms)  367 (6)  336 (6)  328 (6)  322 (6)  335 (6)  380 (5)  349 (5)  336 (5)  332 (5)  341 (5)
Error rates (%)  0.3 (0.1)  1.3 (0.3)  2.7 (0.4)  3.7 (0.5)  2.6 (0.5)  0.1 (0.1)  1.0 (0.2)  2.3 (0.4)  2.5 (0.4)  2.9 (0.4)
iOr
RT (ms)  −8  −30  −42  −38  −22  5  −12  −39  −34  −23
Error rates (%)  −0.1  −0.2  0.1  0.4  −0.6  −0.1  −0.2  0.1  0.1  0.9
Significant group difference; *p < 0.05. Standard errors in parentheses.Frontiers in Human Neuroscience  www.frontiersin.org  July 2010  | Volume 4  | Article 53  |  5
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